ISSN: 2530-0164

Indexed in:

Index Medicus/MEDLINE, Excerpta Medica/EMBASE, SCOPUS, Science Citation Index Expanded, Journal Citation Reports/Science Edition, IBECS

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2023

1.8

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

2.1

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.355

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.474

View more metrics

Journal Information

Congress

Congress content

Congress

XXXV Congreso de la Sociedad Española de Diabetes

Granada, 10 - 13 April 2024

List of sessions

Descargar el PDF completo del suplemento

XXXV Congreso de la Sociedad Española de Diabetes

List of sessions

Descargar el PDF completo del suplemento

Session

Session information

18. OBESIDAD

TYPE: PÓSTERES

Communications

P-097¿SE REQUIERE QUE LAS PREDIABETES ALCANCEN UN ESTADO DE DIABETES DESCONTROLADA PARA OBTENER UN TRATAMIENTO ASEQUIBLE PARA LA OBESIDAD?

V. Pérez de Arenaza Pozo, J. Cárdenas Salas, B.L. Luca, C. Martín Márquez, R.M. Sierra Poyatos, C. Casado Cases, M.C. Sánchez Chiriboga, C. Luengo Álvarez de Buergo, B. Baraia Etxaburu Astigarraga y C. Vázquez Martínez

Hospital Fundación Jiménez Díaz, Madrid, España.

P-098TIRZEPATIDA VS. SEMAGLUTIDA 2,4 MG PARA PERSONAS CON OBESIDAD O SOBREPESO Y DIABETES TIPO 2

C. Fernández^a, E. Hankosky^b, J. Fraseur Brumm^b, R. Malik^b, A. Niemeyer^b, F. Wang^b, X. Michelle Zhang^b y X. He^b

^aEli Lilly and Company, Alcobendas, España. ^bEli Lilly and Company, Indianápolis, EE.UU.